scholarly journals Patients as qualitative data analysts: Developing a method for a process evaluation of the ‘Improving the Safety and Continuity of Medicines management at care Transitions’ (ISCOMAT) cluster randomised control trial

2021 ◽  
Author(s):  
Catherine Powell ◽  
Hanif Ismail ◽  
Richard Cleverley ◽  
Andrew Taylor ◽  
Liz Breen ◽  
...  
Keyword(s):  
Process Evaluation ◽  
Qualitative Data ◽  
Care Transitions ◽  
Randomised Control Trial ◽  
Medicines Management ◽  
Cluster Randomised ◽  
Cluster Randomised Control Trial

scholarly journals Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial

BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e040493
Author(s):  
Catherine Powell ◽  
Liz Breen ◽  
Beth Fylan ◽  
Hanif Ismail ◽  
Sarah L Alderson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Process Evaluation ◽  
Controlled Trial ◽  
Transitions Of Care ◽  
Randomised Control Trial ◽  
Behavioural Intervention ◽  
Medicines Management ◽  
Care Programme ◽  
Cluster Randomised ◽  
The Uk

IntroductionA key priority for the UK National Health Service and patients is to ensure that medicines are used safely and effectively. However, medication changes are not always optimally communicated and implemented when patients transfer from hospital into community settings. Heart failure is a common reason for admission to hospital. Patients with heart failure have a high burden of morbidity, mortality and complex pharmacotherapeutic regimens. The Improving the Safety and Continuity Of Medicines management at Transitions of care programme comprises a cluster randomised controlled trial which will test the effectiveness of a complex behavioural intervention aimed at improving medications management at the interface between hospitals discharge and community care. We will conduct a rigorous process evaluation to inform interpretation of the trial findings, inform implementation of the intervention on a wider scale and aid dissemination of the intervention.Methods and analysisThe process evaluation will be conducted in six purposively selected intervention sites (ie, hospital trusts and associated community pharmacies) using a mixed-methods design. Fidelity and barriers/enablers of implementation of the Medicines at Transitions Intervention (MaTI) will be explored using observation, interviews (20 patients, 40 healthcare professionals), surveys and routine trial data collection on adherence to MaTI. A parallel mixed analysis will be applied. Qualitative data will be thematically analysed using Framework analysis and survey data will be analysed descriptively. Data will be synthesised, triangulated and mapped to the Consolidated Framework for Implementation Research where appropriate. The process evaluation commenced on June 2018 and is due to end on February 2021.Ethics and disseminationApproved by Research Ethics Committee and the UK Health Research Authority REC: 18/YH/0017/IRAS: 231 431. Findings will be disseminated via academic and policy conferences, peer-reviewed publications and social media.Trial registration numberISRCTN66212970.

Improving general practice consultations for older people with asthma: a cluster randomised control trial

2009 ◽  
Vol 191 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Dianne P Goeman ◽  
Lena A Sanci ◽  
Simon L Scharf ◽  
Michael Bailey ◽  
Robyn E O’Hehir ◽  
...  
Keyword(s):  
General Practice ◽  
Older People ◽  
Randomised Control Trial ◽  
Cluster Randomised ◽  
Cluster Randomised Control Trial

Improving general practice consultations for older people with asthma: a cluster randomised control trial

2009 ◽  
Vol 191 (5) ◽  
pp. 296-296
Author(s):  
Dianne P Goeman ◽  
Lena A Sanci ◽  
Simon L Scharf ◽  
Michael Bailey ◽  
Robyn E O’Hehir ◽  
...  
Keyword(s):  
General Practice ◽  
Older People ◽  
Randomised Control Trial ◽  
Cluster Randomised ◽  
Cluster Randomised Control Trial
Sign in / Sign up

Export Citation Format

Share Document